News

Gustave Roussy in the world's TOP 3 cancer hospitals

Gustave Roussy comes in 3rd place in the ranking of specialized hospitals published by the American magazine Newsweek.

Published on

Changed on

Gustave Roussy comes in 3rd place in the ranking of specialized hospitals published by the American magazine Newsweek. This place on the world podium of the best hospitals in oncology reflects the international base of the Institute, both in terms of clinical research and major publications and in terms of innovations towards patients living with cancer.

The “World’s Best Specialized Hospital” ranking, published on September 14 by Newsweek magazine and Statista, identifies and honors the best hospitals around the world in 11 disciplines including oncology. For the year 2023, Gustave Roussy ranks 3rd in the world for the best cancer hospitals.

“This distinction makes us extremely proud. This is a recognition for all the professionals at Gustave Roussy who mobilize on a daily basis to cure cancer in adults and children in the 21st century. This 3rd place in the world also forces us to improve our infrastructures to offer our patients the best care pathways beyond treatment. This is Gustave Roussy's ambition for 2030 with massive real estate investments to renovate our hospitalization units, create new buildings dedicated to the prevention and rapid diagnosis, and build a new research campus", comments the Prof. Fabrice Barlesi, Managing Director of Gustave Roussy.

Recognized as a major player worldwide for its early trials in immunotherapy and precision medicine, the institute has many researchers who are regularly awarded prizes at international congresses or learned societies.

This ranking was established based on the results of an online survey conducted in the summer of 2022 among 40,000 health professionals (doctors, caregivers, hospital directors).

► More information on the Newsweek website

Last news

  • Two photon-counting CT scanners now equip Gustave Roussy's imaging department

    Since September 2026, Gustave Roussy's Department of Medical Imaging has been equipped with a second photon-counting CT scanner, delivering higher image resolution while reducing the doses of X-rays and contrast agent administered to patients. This technology recently enabled the Institute to perform an iodine-free pulmonary CT angiogram, a world first.

    Photographie du scanner à comptage photonique
  • Prevention and screening: getting ahead of lung cancer

    To mark Thoracic Cancer Awareness Month and Tobacco-Free Month, two campaigns focusing on lung cancer, Gustave Roussy highlights its initiatives to advance prevention and screening among people at increased risk. Since its creation in 2021, the Institute’s Interception Lung programme has welcomed more than 900 participants, supporting them to stop smoking and offering personalised screening for the disease.

    Photographie : patient effectuant un scanner thoracique et équipes soignantes
  • Gustave Roussy Meets His Audience

    As part of its awareness-raising and fundraising efforts, Gustave Roussy is currently conducting a door-to-door outreach campaign in several towns in Val-de-Marne (Fresnes, Vitry-sur-Seine, Nogent-sur-Marne, Bry-sur-Marne, Le Kremlin-Bicêtre) from Monday through Saturday, 1:30 p.m. to 8:00 p.m.

    Deux personnes en charge de la collecte porte-à-porte
  • Mens November: Take care of your jewelry its precious!

    November is the month dedicated to raising awareness and promoting prevention of male cancers, which include prostate, testicular, and penile cancers. The goal is to raise public awareness of these diseases—which account for approximately 63,000 new cases in France each year—and to encourage men to perform testicular self-exams, a simple step that can help detect a lump, the nature of which must then be determined through further medical examinations. Gustave Roussy has extensive expertise in the treatment of male cancers, particularly through its Genitourinary Oncology Committee, which is deeply involved in research on these diseases. 

    Visuel fixe campagne novembre masculin